{"id":308253,"date":"2019-12-03T23:00:15","date_gmt":"2019-12-04T07:00:15","guid":{"rendered":"https:\/\/nai500.com\/?p=308253"},"modified":"2019-12-03T23:00:40","modified_gmt":"2019-12-04T07:00:40","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be-rapt-%e4%b8%8e-hanmi-%e5%90%88%e4%bd%9c-adamas-pharm-cowen-%e8%be%be%e6%88%90%e4%ba%a4%e6%98%93","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/12\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e7%b2%be-rapt-%e4%b8%8e-hanmi-%e5%90%88%e4%bd%9c-adamas-pharm-cowen-%e8%be%be%e6%88%90%e4%ba%a4%e6%98%93\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014RAPT\u4e0eHanmi\u5408\u4f5c\uff0cAdamas Pharma\u4e0eCowen\u8fbe\u6210\u4ea4\u6613\uff0c\u963f\u65af\u5229\u5eb7\u51fa\u552e\u7f8e\u56fd\/\u52a0\u62ff\u5927\u7684\u7248\u6743"},"content":{"rendered":"

RAPT\u4e0eHanmi\u5408\u4f5c\u5728\u4e9a\u6d32\u5f00\u53d1FLX475\uff1b\u76d8\u540e\u80a1\u4ef7\u4e0a\u6da812%<\/h2>\n

RAPT Therapeutics\uff08NASDAQ\uff1aRAPT\uff09<\/a>\u5c06\u4e0e\u97e9\u56fdHanmi Pharmaceutical Co.\uff0cLtd.\u5408\u4f5c\uff0c\u5728\u4e9a\u6d32\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u764c\u75c7\u5019\u9009\u836f\u7269CCR4\u62ee\u6297\u5242\u75c7FLX475\u3002<\/p>\n

\u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0cRAPT\u5c06\u83b7\u5f97$1000\u4e07\u7684\u9884\u4ed8\u6b3e\uff0c\u9ad8\u8fbe$4800\u4e07\u7684\u5f00\u53d1\u91cc\u7a0b\u7891\u4ed8\u6b3e\u3001\u9ad8\u8fbe$6000\u4e07\u7684\u9500\u552e\u91cc\u7a0b\u7891\u4ed8\u6b3e\u4ee5\u53ca\u6743\u5229\u91d1\u3002Hanmi\u5c06\u5728\u97e9\u56fd\u548c\u4e2d\u56fd\uff08\u5305\u62ec\u53f0\u6e7e\u548c\u9999\u6e2f\uff09\u83b7\u5f97FLX475\u7684\u72ec\u5bb6\u8bb8\u53ef\u6388\u6743\u3002<\/p>\n

RAPT\u80a1\u4ef7\u6570\u5c0f\u65f6\u540e\u4e0a\u6da812%\u3002<\/p>\n

Adamas Pharma\u4e0eCowen\u8fbe\u6210$5000\u4e07\u7684\u80a1\u7968\u9500\u552e\u534f\u8bae<\/h2>\n

Adamas Pharmaceuticals\uff08NASDAQ\uff1aADMS\uff09<\/a>\u5728\u4e0eCowen\u8fbe\u6210\u51fa\u552e\u9ad8\u8fbe$5000\u4e07\u666e\u901a\u80a1\u7684\u534f\u8bae\u540e\uff0c\u80a1\u4ef7\u76d8\u540e\u4e0b\u8dcc1%\u3002Cowen\u5c06\u4e3a\u6b64\u4ed8\u51fa3%\u7684\u4f63\u91d1\u3002<\/p>\n

Aerie Pharma\u5728\u6b27\u6d32\u63d0\u4ea4Roclanda\u7533\u8bf7<\/h2>\n

Aerie Pharmaceuticals\uff08NASDAQ\uff1aAERI\uff09<\/a>\u5df2\u5728\u6b27\u6d32\u63d0\u4ea4Roclanda\u7684\u4e0a\u5e02\u7533\u8bf7\uff0c0.02%\/0.005%\u7684Roclanda\uff08\u5948\u5854\u8212\u5730\u5c14\u548c\u62c9\u5766\u524d\u5217\u7d20\u773c\u7528\u6eb6\u6db2\uff09\u7528\u4e8e\u964d\u4f4e\u5f00\u89d2\u578b\u9752\u5149\u773c\u6216\u9ad8\u773c\u538b\u60a3\u8005\u7684\u773c\u538b\u3002<\/p>\n

\u8be5\u4ea7\u54c1\u5df2\u4e8e3\u6708\u5728\u7f8e\u56fd\u83b7\u5f97\u6279\u51c6\uff0c\u5546\u6807\u540d\u4e3aRocklatan\u3002<\/p>\n

\u963f\u65af\u5229\u5eb7\u51fa\u552eSeroquel\u4ea7\u54c1\u7ebf<\/h2>\n

\u963f\u65af\u5229\u5eb7\uff08NYSE\uff1aAZN\uff09<\/a>\u540c\u610f\u653e\u5f03\u7f8e\u56fd\u548c\u52a0\u62ff\u5927\u5bf9Seroquel\u548cSeroquel XR\u7684\u6743\u5229\uff0c\u5c06\u4e4b\u4ea4\u4ed8\u7ed9Cheplapharm Arzneimittel GmbH\u3002<\/p>\n

\u6839\u636e\u8be5\u534f\u8bae\u7684\u6761\u6b3e\uff0cCheplapharm\u5c06\u5411\u963f\u65af\u5229\u5eb7\u652f\u4ed8$3500\u4e07\u7684\u9884\u4ed8\u6b3e\u4ee5\u53ca\u6700\u591a$600\u4e07\u7684\u9500\u552e\u8d39\u7528\u3002\u8be5\u516c\u53f8\u5c06\u5728\u8fc7\u6e21\u671f\u95f4\u7ee7\u7eed\u5236\u9020\u548c\u4f9b\u5e94\u4ea7\u54c1\u3002<\/p>\n

Seroquel\u57282018\u5e74\u5728\u4e24\u56fd\u7684\u9500\u552e\u989d\u4e3a$3600\u4e07\uff0c\u800cSeroquel XR\u7684\u9500\u552e\u989d\u4e3a$7900\u4e07\u3002<\/p>\n

Cheplapharm\u5728\u5927\u591a\u6570\u6b27\u6d32\u5e02\u573a\u548c\u4fc4\u7f57\u65af\u62e5\u6709\u8fd9\u4e9b\u836f\u7269\u7684\u6743\u5229\u3002<\/p>\n

\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u7684MDS\u6cbb\u7597\u836f\u7269luspatercept\u63a5\u53d7\u5ba1\u6838<\/h2>\n

FDA\u80bf\u7624\u836f\u7269\u54a8\u8be2\u59d4\u5458\u4f1a\u5c06\u4e8e12\u670818\u65e5\u661f\u671f\u4e09\u5f00\u4f1a\uff0c\u4ee5\u5ba1\u67e5\u548c\u8ba8\u8bba\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\uff08BMY-0.4%\uff09<\/a>\u8865\u5145\u8425\u9500\u7533\u8bf7\uff0c\u8be5\u7533\u8bf7\u5bfb\u6c42\u6279\u51c6\u4f7f\u7528Reblozyl\uff08luspatercept-aamt\uff09\u6cbb\u7597\u60a3\u6709\u9aa8\u9ad3\u589e\u751f\u5f02\u5e38\u7efc\u5408\u75c7\uff08MDS\uff09\u7684\u60a3\u8005\uff0c\u7279\u522b\u662f\u90a3\u4e9b\u60a3\u6709MDS\u76f8\u5173\u6027\u8d2b\u8840\u7684\u4e2d\u4f4e\u98ce\u9669\u7684\u4eba\u3002<\/p>\n

FDA\u4e0a\u4e2a\u6708\u6279\u51c6\u4e86\u7c7b\u7ea2\u7ec6\u80de\u6210\u719f\u5242\u7528\u4e8e\u6cbb\u7597\u9700\u8981\u5b9a\u671f\u8f93\u6ce8\u7ea2\u7ec6\u80de\u7684\u6210\u4eba\u03b2\u5730\u4e2d\u6d77\u8d2b\u8840\u60a3\u8005\u7684\u8d2b\u8840\u3002<\/p>\n

\u8be5\u516c\u53f8\u6b63\u5728\u4e0eAcceleron Pharma\uff08XLRN -0.7%\uff09<\/a>\u5408\u4f5c\u5f00\u53d1\u8be5\u836f\u7269\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

RAPT Therapeutics (NASDAQ:RAPT) will collaborate with South Korea’s Hanmi Pharmaceutical Co., Ltd. to develop and commercialize cancer candidate FLX475, a CCR4 antagonist, in Asia.<\/p>\n","protected":false},"author":9,"featured_media":308233,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[],"class_list":["post-308253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans","exchange-otcqb-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/308253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=308253"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/308253\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/308233"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=308253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=308253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=308253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}